Rozrolimupab
id:
rozrolimupab-284-8044053
title:
Rozrolimupab
text:
Rozrolimupab is a recombinant antibody mixture, specifically containing 25 Rhesus D, or RhD, human antibodies, and is currently under development by Symphogen for the treatment of immune thrombocytopenic purpura (ITP) and for the prevention of hemolytic disease of the newborn (HDN).
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Rozrolimupab
date created:
date modified:
2022-11-26T19:46:45Z
main entity:
{"identifier":"Q7375407","url":"https://www.wikidata.org/entity/Q7375407"}
image:
fields total:
13
integrity:
14